Position in OMER
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,829,315
+$804,150 QoQ
Shares Held
402,662
+40.6% QoQ
Ownership
0.556%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 172 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. OMER ranks #128 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in OMER
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,829,315 | 402,662 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,025,165 | 286,474 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,015,325 | 524,757 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,826,587 | 933,314 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,010,657 | 670,219 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $868,352 | 105,639 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,610,351 | 162,991 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $594,666 | 149,790 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $647,350 | 159,446 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $189,467 | 54,918 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $155,652 | 47,600 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $448,114 | 153,464 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $325,312 | 59,800 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $278,070 | 59,800 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $450,275 | 199,237 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $309,317 | 98,196 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,891,736 | 687,904 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,362,989 | 226,787 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,525,684 | 548,318 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,058,608 | 221,799 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,866,533 | 395,319 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,062,337 | 284,401 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $1,293,181 | 87,852 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $674,690 | 50,463 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||